U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07416838) titled 'Quality of Life and Cognitive Functioning in Patients With Glial Tumors' on Feb. 06.
Brief Summary: The aim of this study is to introduce appropriate assessment instruments and to define patients with gliomas according to cognitive functioning and quality of life. The study will evaluate cognitive functioning as a prognostic factor for survival in patients with glial tumors and will support optimization of treatment strategies to improve patients' quality of life.
Study Start Date: Sept. 21, 2018
Study Type: INTERVENTIONAL
Condition:
Glial Tumors
Intervention:
OTHER: Cognitive Functioning and Quality of Life Assessment
Assess...